Flu vaccine case_study(slideshare)-19_jan2012
-
Upload
huong-eva -
Category
Health & Medicine
-
view
1.563 -
download
0
description
Transcript of Flu vaccine case_study(slideshare)-19_jan2012
PUBLIC POLICY CASE STUDY
A review of the case study on 2004/05 U.S. Influenza Vaccine Shortage
The case is intended solely as a vehicle for classroom discussion
Public Policy & Management classCarnegie Mellon University – Adelaide
Jan 2012
OUTLINE An overview
Underlying Issues
Possible Solutions
Recommendations
1
2
3
4
OVERVIEW
Concerns raised about the fragile US vaccine situation
FLU:36,000 deaths 200,000 hospitalizations
$11-18 billion
2004-2005, US FLU VACCINE SHORTAGE
Vaccine manufacturer was suspended by England
US couldn't get half of expected 100 mil doses90mil at high risk
Pricing gaugingDistribution issues
Government's actions: InvestigationHigh risk areas were set priority
Started to search for additional vaccine supplyImported costly flu shots
High lack of vaccine supply remained Health threat remained
What if this was a flu pandemic?
FDA
Vaccine Manufacturers
People
(including) Media/ Public Relations Plan
CDC MHRA
Private hospitals
Media
High risk population
•High FDA quality standards;•Poor analytical tools;•Weak M&E system;•Disconnect between public and private sectors;•Feeble intra/inter governmental cooperation;•Poor communication
ISSUES UNDERLYING
• Production plants take time to set up
• Vaccine production is time consuming
• High-risk market• High long-term production
costs• Low profit margins
VACCINE PRODUCTION
• Media frenzy;• Public health threat;• Public agitation;• Vaccine smuggling and theft;• Movement to Canada for flu vaccine shots;• Additional costs
FLU VACCINE CRISIS
PUBLIC ADMINISTRATION SYSTEM
CRISIS RESPONSE• CDC recommended that vaccines be reserved for high risk patients (it
however lacked the authority to enforce it).
• A panel to investigate the ethics of distribution was established by CDC.
• A flu vaccine task force was assembled to help manage the distribution
and control price.
• Hospitals started sharing vaccines and doses from federal employees were
diverted to high-risk civilians.
• US government (Federal and State) went international to source vaccines
(efforts were restrained by FDA standards and procedures).
• Delayed supplies led to excess unutilized stock of vaccines.
POSSIBLE SOLUTIONS
1. Timely information management on public health issues.
2. Closer cooperation & alignment with other countries/international bodies (the Medicines and Healthcare Products Regulatory Agency in Britain and the US National Vaccine Advisory Committee/Federal Drug Administration).
3. Develop a more cohesive and coherent crisis management plan among the federal, state government and private agencies focused on resilience and continuity.
4. Review FDA approval/quality assurance procedures to ensure timeliness without compromising standards.
5. Develop Monitoring and Evaluation system to track problems identified as well as facilitate prompt implementation of proposed solutions.
6. Public-Private Partnerships to ensure timely production and distribution of adequate flu vaccines.
RECOMMENDATIONS
Public-Private Partnerships to ensure timely production and distribution of adequate flu vaccines.
RECOMMENDATIONS
Develop Monitoring and Evaluation system to track problems identified as well as facilitate prompt implementation of proposed solutions.
RECOMMENDATIONS
Develop a more cohesive and coherent crisis management plan among the federal, state government and private agencies focused on resilience and continuity. End.
RECOMMENDATION SUMMARY
Vaccine Production
Industry
Public Administration
SystemFlu Situation
Monitoring &Evaluation System Q&A ?
THANK YOU !
The case is intended solely as a vehicle for classroom discussionFlu Virus: Deccanherald
Images on the Newspaper page: Washington Post, AFP, Getty Images
Other photos : unknown authors on Google Images, thank you.
Group members:
Do Thi Thien-huong
Nguyen Thi Huyen
Linh
Oteng Karikari
Chikezie Isiguzo
Stephen Kihato